483 related articles for article (PubMed ID: 8165983)
1. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
[TBL] [Abstract][Full Text] [Related]
2. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
[TBL] [Abstract][Full Text] [Related]
3. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
[TBL] [Abstract][Full Text] [Related]
4. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
Taylor R; Page A; Bampton D; Estoesta J; Rickard M
J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
[TBL] [Abstract][Full Text] [Related]
5. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
May DS; Lee NC; Nadel MR; Henson RM; Miller DS
AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
[TBL] [Abstract][Full Text] [Related]
6. Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer.
Wu JC; Hakama M; Anttila A; Yen AM; Malila N; Sarkeala T; Auvinen A; Chiu SY; Chen HH
Breast Cancer Res Treat; 2010 Jul; 122(2):553-66. PubMed ID: 20054645
[TBL] [Abstract][Full Text] [Related]
7. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
8. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
9. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
10. Screening Mammography Program of British Columbia: pattern of use and health care system costs.
Olivotto IA; Kan L; Mates D; King S
CMAJ; 1999 Feb; 160(3):337-41. PubMed ID: 10065075
[TBL] [Abstract][Full Text] [Related]
11. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic mode and tumor staging of breast cancers in the setting of opportunistic screenings].
Graf O; Obermayer M; Scheurecker A; Hopf G; Kramer J; Frühwald F
Rofo; 2006 Feb; 178(2):221-6. PubMed ID: 16435254
[TBL] [Abstract][Full Text] [Related]
13. The British Columbia Mammography Screening Program: evaluation of the first 15 months.
Burhenne LJ; Hislop TG; Burhenne HJ
AJR Am J Roentgenol; 1992 Jan; 158(1):45-9. PubMed ID: 1307850
[TBL] [Abstract][Full Text] [Related]
14. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening.
Hofvind S; Skaane P
Rofo; 2012 May; 184(5):437-42. PubMed ID: 22426937
[TBL] [Abstract][Full Text] [Related]
15. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
[TBL] [Abstract][Full Text] [Related]
16. Update of the Swedish two-county program of mammographic screening for breast cancer.
Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O
Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926
[TBL] [Abstract][Full Text] [Related]
17. Reviewing interval cancers: time well spent?
Gower-Thomas K; Fielder HM; Branston L; Greening S; Beer H; Rogers C
Clin Radiol; 2002 May; 57(5):384-8. PubMed ID: 12014936
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer mortality after screening mammography in British Columbia women.
Coldman A; Phillips N; Warren L; Kan L
Int J Cancer; 2007 Mar; 120(5):1076-80. PubMed ID: 17149701
[TBL] [Abstract][Full Text] [Related]
19. Mammographic screening reduces risk of breast carcinoma recurrence.
Immonen-Räihä P; Kauhava L; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
Cancer; 2005 Feb; 103(3):474-82. PubMed ID: 15611974
[TBL] [Abstract][Full Text] [Related]
20. Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study.
Musolino A; Michiara M; Conti GM; Boggiani D; Zatelli M; Palleschi D; Bella MA; Sgargi P; Di Blasio B; Ardizzoni A
J Clin Oncol; 2012 Jul; 30(19):2362-8. PubMed ID: 22585698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
